OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

CALR-Mutated MPN: A Shared Neoantigen Makes Immunotherapy Possible, and Antibodies Lead So Far

Anthropic CEO Dario Amodei: Can AI Cure Cancer by 2036?

UICC Wins Best International Association Award at the Association Excellence Awards 2026 in London

One Procedure, Two Goals: Lung Biopsy and Cryoablation Show Promising Results in Early-Stage NSCLC

YOGI Aims to Create New Opportunities for Young GI Oncologists Across Europe - CancerWorld

Oncology News, Insights, Stories by OncoDaily

Joe Biden
Voices

Joe Biden: I Know Firsthand the Toll of This Disease, Get Screened

Durvalumab
FDA Approvals

FDA Approves Durvalumab Plus Enfortumab Vedotin for Muscle-Invasive Bladder Cancer

Belzutifan
Genitourinary Oncology

Belzutifan Plus Lenvatinib Moves Closer to EU Approval for Advanced Kidney Cancer

UICC Wins Best International Association Award at the Association Excellence Awards 2026 in London

YOGI Aims to Create New Opportunities for Young GI Oncologists Across Europe - CancerWorld

Anthropic CEO Dario Amodei: Can AI Cure Cancer by 2036?

One Procedure, Two Goals: Lung Biopsy and Cryoablation Show Promising Results in Early-Stage NSCLC

CALR-Mutated MPN: A Shared Neoantigen Makes Immunotherapy Possible, and Antibodies Lead So Far

Ryan Schoenfeld: A Call for Tech Leaders to Support the Future of Cancer Research

Filipe Coutinho: New Review Explores How Biological Ageing Shapes Cancer Treatment and Outcomes

Voices
Balazs Halmos

Balazs Halmos: Great Scientific Exchange at the 21st NY Lung Cancer Conference

Michael Sapienza Highlights New Bipartisan Bill to Address Rising Colorectal Cancer in Young Adults

Mike Linn: Rediscovering Physical and Emotional Well-Being Beyond Cancer Treatment

Zinia Han Reflects on Inspiring Mentorship at WRAD Conference

Pramesh CS Urges Public to Step Forward as Tata Memorial Faces Blood Shortage

Joseph Maakaron: New Evidence Challenges MMF Use in Matched-Donor HCT

Julio Delgado: Hospital Clínic Barcelona Launches First CAR-T Clinical Trial for HER2+ Breast Cancer

FDA Approvals
Durvalumab

FDA Approves Durvalumab Plus Enfortumab Vedotin for Muscle-Invasive Bladder Cancer

FDA Approves Pimicotinib for TGCT Following Positive Phase 3 MANEUVER Trial Results

After a Decade Without a New Option, FDA Approves Amivantamab for Head and Neck Cancer

FDA Approves Pirtobrutinib for First-Line CLL/SLL Without 17p Deletion, a First for Non-Covalent BTK Inhibitors

Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications

Niklas Klümper: FDA Approves Belzutifan Plus Lenvatinib in Advanced ccRCC

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Celebrities and Cancer

OncoCalendar

ESMO AI and Digital Oncology Congress 2026

European Society For Medical Oncology (ESMO)

16 Nov
ESMO

NCI Data Jamboree: Enhancing Data Sharing and Utility to Advance Cancer Research

National Cancer Institute

16 Nov
NCI Data Jamboree

ESTRO Advanced Imaging in Radiotherapy: Current Use, Future Developments, and the Integration of AI

European Society for Radiotherapy and Oncology (ESTRO)

16 Nov
Radiotherapy

Career Masterclass for Early Career Cancer Researchers

European Association for Cancer Research

17 Nov
Early Career Cancer Researchers

SIOP – Navigating Transition in Childhood Cancer Survivorship

International Society of Paediatric Oncology (SIOP)

17 Nov
Childhood Cancer

38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026)

European Organisation for Research and Treatment of Cancer

18 Nov
EORTC-NCI-AACR

European Cancer Summit 2026

European Cancer Organisation (ECO)

18 Nov
ECO

31st CTOS Annual Meeting 2026

Connective Tissue Oncology Society

18 Nov
CTOS

ESMO Deep Dive: Are We Defeating Cervical Cancer?

European Society For Medical Oncology (ESMO)

18 Nov
ESMO Deep Dive

Irish Thoracic Society Annual Scientific Meeting 2026

Irish Thoracic Society

19 Nov
Irish Thoracic Society

ESSO Basics in Liver Surgery Course

European Society of Surgical Oncology

19 Nov
Liver Surgery

The 2026 International Kidney Cancer Symposium (IKCS)

Kidney Cancer Association

19 Nov
Kidney Cancer Symposium

Immune-oncology
Beyond MSI Status: A New Biomarker of Immunotherapy Resistance in Colorectal Cancer

Beyond MSI Status: A New Biomarker of Immunotherapy Resistance in Colorectal Cancer

Antibiotics and Immunotherapy: What a 97,850-Patient Meta-Analysis Reveals

Beyond Checkpoint Inhibitors: The Rise of T-Cell Engagers in Prostate Cancer

Rituximab and Checkpoint Inhibitors: A New Strategy to Prevent Immune-Related Toxicity

PD-L1: One Biomarker, Three Different Scores

NEO-CESQ Trial: Can Molecular Biomarkers Predict Recurrence After Immunotherapy?

Professor Gianluca Franceschini on Surgical De-escalation: Rethinking Breast Surgery in the Immunotherapy Era

Gastrointestinal-Oncology
GeNeS1S

GeNeS1S Trial: Gemcitabine, Nab-Paclitaxel, and S-1 in Advanced Pancreatic Cancer

It Is Time for Collaboration, Not Fragmentation: Why Colorectal Cancer Screening Must Become a Shared Priority in Kenya

Neoadjuvant vs Definitive ChemoRT in cN3M0 Esophageal Cancer: A Nationwide Dutch Study

Tumor Budding in Colorectal Cancer: Grading and Prognosis

CEA Levels in Colorectal Cancer: Monitoring and Recurrence

Adagene Completes Phase 2 Enrollment for Muzastotug Plus Pembrolizumab in MSS Colorectal Cancer

10 Must-Read Posts in GI Oncology This Week

Breast-Oncology
Luminal Breast Cancer

Hidden Basal-Like Cells in Luminal Breast Cancer: Nature Study Reveals New Epigenetic Signals of Recurrence

Beyond Cancer Survival: New Study Links Chemotherapy to Accelerated Biological Aging in Breast Cancer

A Second Chance at Breast Conservation: Reirradiation Challenges Mastectomy After Local Recurrence

Breast Cancer in Michelangelo’s Sistine Chapel? A 500-Year-Old Fresco Sparks a Modern Medical Debate

Premenopausal Breast Cancer: New Review Challenges One-Size-Fits-All Adjuvant Treatment Strategies

Pembrolizumab Achieves 70.8% Pathological Complete Response in Early TNBC: French Real-World Study Examines Treatment Delivery and Safety

ESMO 2026 Reshapes Metastatic Breast Cancer Treatment: ADCs Move Into First Line as Biomarkers Guide New Strategies

Lung-Oncology
Lung Cancer

International Lung Cancer Summit 2026: From Molecular Targets to the Next Era of Precision Thoracic Oncology

Zipalertinib Plus Chemotherapy Moves Toward FDA Review After Six-Month PFS Benefit in EGFR Exon 20 Insertion-Mutated Lung Cancer

One Procedure, Two Goals: Lung Biopsy and Cryoablation Show Promising Results in Early-Stage NSCLC

Beyond TROP2 Expression: AI-Based Biomarker May Predict Datopotamab Deruxtecan Benefit in Lung Cancer

Beyond EGFR Mutations: New Study Reveals Why Some Lung Cancer Cells Survive Osimertinib

Split-Course Lung SBRT: Novel Inhale–Exhale Technique May Reduce Rib and Chest Wall Radiation Exposure

HERON-Lung01: Ruzaltatug Rezetecan Reduces Progression Risk in EGFR-Mutated NSCLC Following EGFR-TKI Therapy

OncoDaily TV
Burnout

Oncology Beyond Guidelines: Burnout, Imposter Syndrome, Mentorship & Cancer Prevention with Imène Hadji

Holistic Healing

Cancer Survivorship, Holistic Healing and Patient Advocacy with Rohini Singh Sisodia

ONCOFFEE

ONCOFFEE: Cancer Care in Nepal, Global Oncology, and Bridging Resource Gaps with Vivek Ghosh

The CML Evolution

The CML Evolution: Mastering Modern Algorithms in Chronic Myeloid Leukemia

Lynda Chin

The Future is Near. Can We Finally Stop Cancer Resistance? Dr. Lynda Chin

AI

Can you trust AI with your CANCER? Shaalan Beg

Christian Ntizimira

Continue to be human: Christian Ntizimira

Stephanie Kauffman

She Left Hollywood To Fight Cancer: Stephanie Kauffman

pablo allard

Childhood Cancer Survivor Who Changed the Law: Pablo Allard’s Advocacy Journey

Cancer Care

Personalizing Colorectal Cancer Care with ctDNA? Dr. Robert Lentz

Priti Patnaik, Independent journalism

Independent journalism in global health: Priti Patnaik

Treatment Paradigms, Karine Tawagi

Evolving Treatment Paradigms in Muscle-Invasive Bladder Cancer

Not To Miss
Zipalertinib

Zipalertinib Plus Chemotherapy Moves Toward FDA Review After Six-Month PFS Benefit in EGFR Exon 20 Insertion-Mutated Lung Cancer

Belzutifan Plus Lenvatinib Moves Closer to EU Approval for Advanced Kidney Cancer

Africa Cancer Control Implementation Forum 2026: Turning Cancer Policies into Better Patient Care

New Prostate Cancer Screening Guidelines Recommend Regular PSA Testing

Daiichi Sankyo Seeks Japan Approval for Trastuzumab Deruxtecan in HER2-Expressing Uterine Carcinosarcoma

Faeth Therapeutics Reports Phase 2 Results for PIKTOR in Endometrial Cancer

Beyond First-Generation ICIs: Module 2 of OncoDaily Academy’s Six-Part Programme on Immune Checkpoint Inhibitors

OncoGrants
Quantitative Biology Fellowship Award

Damon Runyon Quantitative Biology Fellowship Award 2027

CRI

CRI Lloyd J. Old STAR Program 2027

RSNA

RSNA Research Seed Grant 2027

AACR

BCRF–AACR Career Development Awards 2027

Fanconi Anemia

ACS–Fanconi Cancer Foundation Discovery Boost Grant: Up to $297,000 for Fanconi Anemia-Associated Cancer Research

John Robert Lewis

AACR-Lustgarten Foundation Career Development Award for Pancreatic Cancer Research - in Honor of John Robert Lewis 2027

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: Current Practice and Evolving Directions

CancerWorld

Oncologists
Verna Vanderpuye

Verna Vanderpuye

Oncologists Location Accra, Ghana
Ninad Katdare

Ninad Katdare

Oncologists Location Mumbai, India
Alessandro Russo

Alessandro Russo

Oncologists Location Milan, Italy
Nazik Hammad

Nazik Hammad

Oncologists Location Toronto, Canada
Gaurav Narula

Gaurav Narula

Oncologists Location Mumbai, India
Piotr J. Wysocki

Piotr J. Wysocki

Oncologists Location Kraków, Poland
Yousef Zakharia

Yousef Zakharia

Oncologists Location Red Wing, USA
Nagashree Seetharamu

Nagashree Seetharamu

Oncologists Location Long Island, USA

Drugs Atlas
Glofitamab (Columvi): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Glofitamab-gxbm (Columvi) Nov 14, 2026 4:01 pm
Mosunetuzumab (Lunsumio, Lunsumio Velo): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Mosunetuzumab-axgb (Lunsumio) Nov 13, 2026 1:26 am
Epcoritamab (Epkinly): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Epcoritamab-bysp (Epkinly) Nov 13, 2026 1:25 am
Blinatumomab (Blincyto): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Blinatumomab (Blincyto) Nov 12, 2026 5:42 am
Inotuzumab Ozogamicin (Besponsa): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Inotuzumab ozogamicin (Besponsa) Nov 12, 2026 5:40 am
Gemtuzumab Ozogamicin (Mylotarg): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Gemtuzumab ozogamicin (Mylotarg) Nov 12, 2026 5:37 am
Brentuximab Vedotin (Adcetris): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Brentuximab Vedotin (Adcetris) Nov 12, 2026 5:35 am
Alemtuzumab (Campath, Lemtrada): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Alemtuzumab (Campath, Lemtrada) Nov 10, 2026 4:31 pm
Elotuzumab (Empliciti): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Elotuzumab (Empliciti) Nov 10, 2026 4:26 pm
Isatuximab (Sarclisa, Sarclisa Escena): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Isatuximab-irfc (Sarclisa, Sarclisa Escena) Nov 8, 2026 1:29 am

OncoDaily Magazine

New Paper Alert
Jordi Remon

Jordi Remon: PECATI Phase 2 Trial Supports Pembrolizumab Plus Lenvatinib in Pretreated Thymic Cancer

Liang Cheng

Liang Cheng: New Review Explores the Future of Urinary Biomarkers and Liquid Biopsies in Bladder Cancer

Niklas Klümper

Niklas Klümper: Membranous NECTIN4 Emerges as a Potential Treatment Biomarker in Urothelial Cancer

Felipe Couñago

Felipe Couñago: Encouraging Long-Term Results of 5-Fraction Breast Radiotherapy

Federico Pio Fabrizio

Federico Pio Fabrizio: Viewpoint Explores the Challenges of NGS Panel Standardization

Filipe Coutinho

Filipe Coutinho: New Review Explores How Biological Ageing Shapes Cancer Treatment and Outcomes

OncoDaily Medical Journal

GU Oncology

10.69690/ODMJ-001-1026-8269

Psychosocial burden and lifestyle impact in patients with renal cell carcinoma: a patient-reported outcomes analysis
Original Research

Pediatric Oncology

10.69690/ODMJ-001-1026-8309

Limited Prognostic Value of Baseline Curie Score in Children with High-Risk Neuroblastoma Treated with Contemporary Multi-modal Therapy: A Single-Center Retrospective Cohort Study
Original Research

Breast Cancer

10.69690/ODMJ-001-1026-8231

Variable-Volume Oncoplastic Reconstruction Using a Modified Würinger Central Pedicle Technique for Upper Quadrants Breast Cancer: a single-center experience
Original Research

GI Oncology

10.69690/ODMJ-001-1026-8138

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Original Research

Oncology Nursing

10.69690/ODMJ-002-0926-8087

Risk of Atrial Fibrillation in Breast Cancer Patients Treated with Radiotherapy: A Scoping Review
Reviews

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews